
Aigle Pharma Private Limited
About Aigle Pharma Private Limited
Data last updated:
Aigle Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 17 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2013PTC068564. Its GSTIN is 29AALCA5666Q1ZO (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivkumar Channabasappa Shetkar (Managing Director) and Sharanabasappa Shetkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 53 2nd Floor 1st D Cross Remco Layout Vijayanagar, Bangalore, Karnataka, India – 560040.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.75 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹12,884 (net margin 0.9%) and EBITDA of ₹13,477 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aigle Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo 53 2nd Floor 1st D Cross Remco Layout Vijayanagar, Bangalore, Karnataka, India – 560040
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Aigle Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aigle Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Aigle Pharma Private Limited, buy the company report.
Financials of Aigle Pharma Private Limited
FY 2025 filings availableAigle Pharma Private Limited reported revenue of ₹13.75 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 30% fall in the latest year. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13,477 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,884 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aigle Pharma Private Limited, buy the company report.
Board of directors of Aigle Pharma Private Limited
Aigle Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivkumar Channabasappa Shetkar | Managing Director | 17 Apr 2013 | 13 Years 7 Months | Current |
| Sharanabasappa Shetkar | Director | 03 Oct 2013 | 13 Years 1 Months | Current |
Peer comparison
Aigle Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Namosidhi Buildcon Private Limited | ₹13.8 Lakh (FY 2025) | 1.0% | Delhi, India | |||
| Bathani Agriculture Farmers Producer Company Limited | ₹13.78 Lakh (FY 2025) | 208.0% | Gaya, Bihar, India | |||
| Divyanka Agencies Private Limited | ₹13.77 Lakh (FY 2025) | Bhubaneswar, Odisha, India | ||||
| Creation Suppliers Private Limited | ₹13.76 Lakh (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Stackknack (OPC) Private Limited | ₹13.75 Lakh (FY 2025) | -53.0% | Faridabad, Haryana, India | |||
| Aigle Pharma Private Limitedthis company | ₹13.75 Lakh (FY 2025) | ₹12,884 | 0.9% | -30.0% | Bangalore, Karnataka, India | |
| Tiro Projects Private Limited | ₹13.75 Lakh (FY 2025) | -69.0% | Navi Mumbai, Maharashtra, India | |||
| Glee Tradex Private Limited | ₹13.74 Lakh (FY 2024) | -53.0% | Delhi, India | |||
| Almond Remedies Private Limited | ₹13.7 Lakh (FY 2023) | 9867.0% | Bangalore, Karnataka, India | |||
| Lanus Lab Private Limited | ₹13.69 Lakh (FY 2025) | -84.0% | Auranagabad, Maharashtra, India | |||
| Mixtech Equipments Private Limited | ₹13.69 Lakh (FY 2024) | Bishrakh, Uttar Pradesh, India |
To see the full peer comparison of Aigle Pharma Private Limited, buy the company report.
Auditor
Aigle Pharma Private Limited is audited by C.M MAHADEV for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C.M MAHADEV | FY 2017 | 219106 |
Shareholding
The shareholding of Aigle Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aigle Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aigle Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aigle Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aigle Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCA5666Q1ZO | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aigle Pharma Private Limited, buy the company report.
Recent activity
Aigle Pharma Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Ramesh Gopinath Mahote ceased to be Director on 16 Oct 2014.
Frequently asked questions
Aigle Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in chemical products, within the chemicals industry. It was incorporated on 17 April 2013 (13+ years old) and is registered under CIN U24230KA2013PTC068564.
Aigle Pharma has 2 current directors:
- Shivkumar Channabasappa Shetkar - Managing Director
- Sharanabasappa Shetkar - Director
The latest financial statements of Aigle Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aigle Pharma is 29AALCA5666Q1ZO, registered in Karnataka.
The CIN (Corporate Identification Number) of Aigle Pharma is U24230KA2013PTC068564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aigle Pharma was incorporated on 17 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Aigle Pharma by revenue are Namosidhi Buildcon Private Limited, Bathani Agriculture Farmers Producer Company Limited, Divyanka Agencies Private Limited, Creation Suppliers Private Limited, Stackknack (OPC) Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Ramesh Gopinath Mahote ceased to be Director on 16 Oct 2014. Sharanabasappa Shetkar ceased to be Additional Director on 30 Sep 2014. Sharanabasappa Shetkar was appointed as Director on 03 Oct 2013. Aigle Pharma has 4 board changes on record in total.
The registered office of Aigle Pharma is at No 53 2nd Floor 1st D Cross Remco Layout Vijayanagar, Bangalore, Karnataka, India – 560040.
Aigle Pharma operates in the chemicals industry, in the chemical products segment.
The compliance status of Aigle Pharma is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.

